Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/31499
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorÁlvarez Jaramillo, Daniel-
dc.contributor.authorRúa Molina, Diana Carolina-
dc.contributor.authorVelásquez Berrío, Manuela-
dc.contributor.authorCataño Bedoya, John Ubeimar-
dc.contributor.authorEscudero, Carlos Alonso-
dc.contributor.authorCadavid Jaramillo, Ángela Patricia-
dc.date.accessioned2022-10-27T17:25:24Z-
dc.date.available2022-10-27T17:25:24Z-
dc.date.issued2022-
dc.identifier.citationÁlvarez D, Rúa C, Velásquez Berrío M, Cataño JU, Escudero C, Cadavid J ÁP. Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox? J Autoimmun. 2022 Sep 15;133:102905. doi: 10.1016/j.jaut.2022.102905. Epub ahead of print. PMID: 36115210.spa
dc.identifier.issn0896-8411-
dc.identifier.urihttps://hdl.handle.net/10495/31499-
dc.description.abstractABSTRACT: Antiphospholipid antibodies (aPL) lead to a hypercoagulable state in vivo. Paradoxically, some of these autoantibodies perform as inhibitors of the coagulation cascade in vitro (a phenomenon referred to as “lupus anticoagulant”). The presence of lupus anticoagulant has been related to an increased quantity of plasma extracellular vesicles, which may constitute a direct procoagulant mechanism in antiphospholipid syndrome. This study investigates whether or not endothelial cell-derived extracellular vesicles released upon stimulation with aPL (aPL-EDEVs) are related to a higher direct coagulation activity. Using an in vitro model of endothelium, flow cytometry and a recalcified plasma-based assay, we found that the coagulation activity of aPL-EDEVs is mainly conditioned by the lupus anticoagulant-like activity of autoantibodies. Nevertheless, in the presence of β2 glycoprotein I, a cofactor of aPL during the stimulation of endothelial cells, the coagulation activity of EDEVs is restored in a mitogen-activated protein kinase kinases 1 and 2 (MEK1/2)-dependent manner. This phenomenon was especially evident when using immunoglobulins G from patients with vascular and obstetric primary antiphospholipid syndrome who manifest refractoriness to treatment. Our findings suggest that the role of aPL-EDEVs in the antiphospholipid syndrome-related hypercoagulable state may not rely on their capacity to enhance clotting directly. While β2 glycoprotein I performs as a procoagulant cofactor and restores the coagulation activity of extracellular vesicles via MEK1/2 pathway, proportionally, autoantibodies interact with aPL-EDEVs and exhaust their coagulation properties. Further analysis is required to establish whether lupus anticoagulant-like autoantibodies opsonise extracellular vesicles and whether opsonised vesicles may lead to thrombosis by indirect means.spa
dc.format.extent12spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleExtracellular vesicles released upon stimulation with antiphospholipid antibodies : An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?spa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación en Trombosisspa
dc.publisher.groupGrupo Reproducciónspa
dc.identifier.doi10.1016/j.jaut.2022.102905-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1095-9157-
oaire.citationtitleJournal of Autoimmunityspa
oaire.citationstartpage1spa
oaire.citationendpage12spa
oaire.citationvolume133spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeLondres, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAnticuerpos Antifosfolípidos-
dc.subject.decsAntibodies, Antiphospholipid-
dc.subject.decsInhibidor de Coagulación del Lupus-
dc.subject.decsLupus Coagulation Inhibitor-
dc.subject.decsQuinasas de Proteína Quinasa Activadas por Mitógenos-
dc.subject.decsMitogen-Activated Protein Kinase Kinases-
dc.subject.decsSíndrome Antifosfolípido-
dc.subject.decsAntiphospholipid Syndrome-
dc.subject.decsTrombosis-
dc.subject.decsThrombosis-
dc.subject.decsVesículas Extracelulares-
dc.subject.decsExtracellular Vesicles-
dc.description.researchgroupidCOL0007631spa
dc.description.researchgroupidCOL0010421spa
dc.relation.ispartofjournalabbrevJ. Autoimmun.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AlvarezDaniel_2022_ExtracellularVesicles.pdfArtículo de investigación5.39 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons